DK2830645T3 - Neuregulin til anvendelse i behandling af perifær nervelæsion - Google Patents

Neuregulin til anvendelse i behandling af perifær nervelæsion

Info

Publication number
DK2830645T3
DK2830645T3 DK13716919.9T DK13716919T DK2830645T3 DK 2830645 T3 DK2830645 T3 DK 2830645T3 DK 13716919 T DK13716919 T DK 13716919T DK 2830645 T3 DK2830645 T3 DK 2830645T3
Authority
DK
Denmark
Prior art keywords
neuregulin
treatment
peripheral nerve
nerve injury
injury
Prior art date
Application number
DK13716919.9T
Other languages
English (en)
Inventor
Anthony O Caggiano
Anthony J Bella
Anindita Ganguly
Jennifer Iaci
Thomas Parry
Raymond Warren Colburn
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Application granted granted Critical
Publication of DK2830645T3 publication Critical patent/DK2830645T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1883Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK13716919.9T 2012-03-30 2013-03-29 Neuregulin til anvendelse i behandling af perifær nervelæsion DK2830645T3 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261618381P 2012-03-30 2012-03-30
US201261674060P 2012-07-20 2012-07-20
US201261693589P 2012-08-27 2012-08-27
US201261693585P 2012-08-27 2012-08-27
US201361785419P 2013-03-14 2013-03-14
PCT/US2013/034634 WO2013149163A1 (en) 2012-03-30 2013-03-29 Use of neuregulin to treat peripheral nerve injury

Publications (1)

Publication Number Publication Date
DK2830645T3 true DK2830645T3 (da) 2017-11-20

Family

ID=48128617

Family Applications (2)

Application Number Title Priority Date Filing Date
DK13716919.9T DK2830645T3 (da) 2012-03-30 2013-03-29 Neuregulin til anvendelse i behandling af perifær nervelæsion
DK17187879.6T DK3278811T3 (da) 2012-03-30 2013-03-29 Anvendelse af ggf2 til behandling af neuropatisk smerte ved peripheral nerveskade

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK17187879.6T DK3278811T3 (da) 2012-03-30 2013-03-29 Anvendelse af ggf2 til behandling af neuropatisk smerte ved peripheral nerveskade

Country Status (16)

Country Link
US (3) US20150094263A1 (da)
EP (3) EP3278811B1 (da)
JP (4) JP6420233B2 (da)
CN (2) CN106511971A (da)
AU (4) AU2013237896B2 (da)
BR (1) BR112014024308B1 (da)
CA (1) CA2869070A1 (da)
DK (2) DK2830645T3 (da)
ES (2) ES2857810T3 (da)
HK (2) HK1206632A1 (da)
IL (3) IL288785B2 (da)
MX (1) MX354598B (da)
NZ (1) NZ700546A (da)
PL (2) PL3278811T3 (da)
PT (2) PT3278811T (da)
WO (1) WO2013149163A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0916442A2 (pt) 2008-07-17 2018-06-19 Acorda Therapeutics, Inc. dosagem terapêutica de uma neuregulina ou de uma subsequência da mesma para tratamento ou profilaxia de insuficiência cardíaca
ES2763086T3 (es) 2009-10-14 2020-05-27 Acorda Therapeutics Inc Uso de una neuregulina para tratar la lesión del nervio periférico
ITUB20155471A1 (it) * 2015-11-11 2017-05-11 Univ Degli Studi Di Torino Coniugato della neuregulina 1 per il trattamento delle lesioni dei nervi periferici
AU2016364992B2 (en) * 2015-12-04 2021-12-09 University Of Iowa Research Foundation Apparatus, systems and methods for predicting, screening and monitoring of encephalopathy / delirium
WO2019099902A1 (en) 2017-11-17 2019-05-23 The Research Foundation for State University of New York A method for treating damaged peripheral nerves using x-ray microbeam irradiation
CN110946991A (zh) * 2018-09-27 2020-04-03 广州中医药大学(广州中医药研究院) 神经调节蛋白1的应用
CN114929099A (zh) * 2019-08-01 2022-08-19 马克·埃文斯 用于在分娩期间和分娩之前降低人类胎儿神经损伤风险及鉴定神经损伤存在的方法和设备
CN116116737B (zh) * 2023-04-14 2023-06-30 新华手术器械有限公司 止血钳毛坯自动上料装置及使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037A (en) 1850-01-22 Grid-ikon slide-valve
US888A (en) 1838-08-20 perkins
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US6087323A (en) * 1992-04-03 2000-07-11 Cambridge Neuroscience, Inc. Use of neuregulins as modulators of cellular communication
US7037888B1 (en) 1992-04-03 2006-05-02 Acorda Therapeutics, Inc. Methods for treating muscle diseases and disorders
JP2001519400A (ja) * 1997-10-14 2001-10-23 ケンブリッジ ニューロサイエンス インク. ニューレグリン使用を含む治療法
JP5324732B2 (ja) * 2000-05-23 2013-10-23 スネス ファーマシューティカルズ インコーポレイテッド Nrg−2核酸分子、ポリペプチド、ならびに診断および治療法
US20100286043A1 (en) * 2007-10-05 2010-11-11 Tufts Medical Center, Inc. Use of neuregulin-1 in reducing brain damage
CN104645315A (zh) * 2008-02-29 2015-05-27 阿索尔达治疗公司 达到所需胶质生长因子2血浆水平的方法
BRPI0916442A2 (pt) * 2008-07-17 2018-06-19 Acorda Therapeutics, Inc. dosagem terapêutica de uma neuregulina ou de uma subsequência da mesma para tratamento ou profilaxia de insuficiência cardíaca
EP2428211A4 (en) * 2009-05-07 2013-04-03 Moon & J Inc PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF NEURAL DAMAGE AND NEUROLOGICAL DISEASES
ES2763086T3 (es) * 2009-10-14 2020-05-27 Acorda Therapeutics Inc Uso de una neuregulina para tratar la lesión del nervio periférico
JP2013535507A (ja) * 2010-08-13 2013-09-12 ジョージタウン ユニバーシティ Ggf2および使用方法

Also Published As

Publication number Publication date
IL288785B2 (en) 2023-03-01
JP7108724B2 (ja) 2022-07-28
JP2019131582A (ja) 2019-08-08
EP3278811A1 (en) 2018-02-07
AU2013237896A1 (en) 2014-10-16
EP2830645B1 (en) 2017-08-30
IL273186B (en) 2022-01-01
AU2019202401B2 (en) 2020-10-15
CA2869070A1 (en) 2013-10-03
JP2015514096A (ja) 2015-05-18
HK1249038A1 (zh) 2018-10-26
EP2830645A1 (en) 2015-02-04
AU2013237896B2 (en) 2017-11-02
PL3278811T3 (pl) 2021-08-02
AU2019202401A1 (en) 2019-05-02
DK3278811T3 (da) 2021-03-01
IL288785B (en) 2022-11-01
PL2830645T3 (pl) 2018-01-31
MX2014011838A (es) 2015-03-09
ES2647917T3 (es) 2017-12-27
PT3278811T (pt) 2021-03-03
IL273186A (en) 2020-04-30
AU2020260539A1 (en) 2020-11-26
BR112014024308A2 (pt) 2017-08-08
JP6420233B2 (ja) 2018-11-07
BR112014024308A8 (pt) 2018-01-23
CN106511971A (zh) 2017-03-22
IL234882B (en) 2020-03-31
IL234882A0 (en) 2014-12-31
US20160346353A1 (en) 2016-12-01
CN104321072A (zh) 2015-01-28
BR112014024308B1 (pt) 2021-11-30
EP3842059A1 (en) 2021-06-30
PT2830645T (pt) 2017-11-28
WO2013149163A1 (en) 2013-10-03
MX354598B (es) 2018-03-12
NZ700546A (en) 2017-05-26
IL288785A (en) 2022-02-01
JP2017149746A (ja) 2017-08-31
ES2857810T3 (es) 2021-09-29
AU2018200592A1 (en) 2018-02-15
JP2021059605A (ja) 2021-04-15
EP3278811B1 (en) 2020-12-02
US20150094263A1 (en) 2015-04-02
HK1206632A1 (en) 2016-01-15
US20230117985A1 (en) 2023-04-20

Similar Documents

Publication Publication Date Title
DK2836200T3 (da) Termoreversible hydrogelpræparater til anvendelse i behandlingen af lidelser i urothelium
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
DK3329884T3 (da) Implanterbar indretning til behandling af glaukom
IL239355A0 (en) Compositions of gamma-hydroxybutyrate and their use in the treatment of disorders
DK3811943T3 (da) Forbindelse til anvendelse til behandling af øjenlidelser
DK2815769T3 (da) Fam19a5 til anvendelse i diagnosticering og behandling af skader på centralnervesystemet
DK2830645T3 (da) Neuregulin til anvendelse i behandling af perifær nervelæsion
DK2838539T3 (da) Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelser
DK2818241T3 (da) Fremgangsmåde til fremstilling af behandlingsapparat udstyret med katalysatorbærende honeycombstruktur
HK1207860A1 (en) 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders 2--5---2h--3-
HK1209424A1 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of reperfusion injury
EP2867239A4 (en) OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DIABETES
BR112013034055A2 (pt) alcaftadina para uso no tratamento de urticária
EP2922536A4 (en) USE OF BUCILLAMINE IN THE TREATMENT OF GOUTTE
HK1217688A1 (zh) -氯- 苯基- -茚- -酮及其用途
DK2892556T3 (da) Sammensætninger og fremgangsmåder til behandling af sygdomme
DK2705847T3 (da) Sammensætning til behandling af psoriasis
ITRM20120530A1 (it) Compounds for use in the treatment of parasitic diseases
ZA201408065B (en) Compositions and methods for the treatment of diabetes
DK2820042T3 (da) Igg-stimuleret remyelinisering af perifere nerver
ITRM20120473A1 (it) Use of glycerophosphoinositols for the treatment of septic shock
PL2861568T3 (pl) Aminy trzeciorzędowe do zastosowania w leczeniu zaburzeń serca
DK2932973T3 (da) Formuleringer til anvendelse til behandling af hudtilstande
LT2863932T (lt) Kompozicija, skirta naudoti limfedemos gydymui
FI10322U1 (fi) Jäteveden puhdistamo